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family of aspartic proteases, the plasmepsins (PMs),
plays a key role in the degradation of hemoglobin in
 
the 
 
Plasmodium falciparum
 
 food vacuole. To study the
trafﬁcking of proPM II, we have modiﬁed the chromosomal
PM II gene in 
 
P. falciparum
 
 to encode a proPM II–GFP
chimera. By taking advantage of green ﬂuorescent protein
ﬂuorescence in live parasites, the ultrastructural resolution
A 
 
of immunoelectron microscopy, and inhibitors of trafﬁcking
and PM maturation, we have investigated the biosynthetic
path leading to mature PM II in the food vacuole. Our data
support a model whereby proPM II is transported through
the secretory system to cytostomal vacuoles and then is
carried along with its substrate hemoglobin to the food vac-
uole where it is proteolytically processed to mature PM II.
 
Introduction
 
The pathology of severe malaria is caused by the intraeryth-
rocytic form of the human parasite 
 
Plasmodium falciparum
 
.
Within the erythrocyte, 
 
P
 
. 
 
falciparum
 
 inhabits a parasi-
tophorous vacuole and from there, directs an extensive reor-
ganization of the host cell which includes major alterations
to the permeability, rigidity, and surface characteristics of
the erythrocyte membrane (Deitsch and Wellems, 1996).
To support its growth and asexual replication, the parasite
undertakes a feeding process whereby it endocytoses a large
quantity of erythrocyte cytosol and digests its primary
constituent, hemoglobin, in an acidic degradative organelle
known as the food vacuole or digestive vacuole (Banerjee
and Goldberg, 2000). Because of the continuing high levels
of morbidity and mortality attributed to this protozoan
parasite, much effort has been directed toward understanding
the cell biology of its intraerythrocytic cycle, which consists
of three morphologically distinct stages: ring, trophozoite,
and schizont. During the ring stage, which lasts 22–24 h
from the time of merozoite invasion, metabolic activity is low.
The trophozoite stage, 10–12 h in duration, is characterized
by an acceleration of metabolic processes that include the
ingestion and digestion of large amounts of host hemoglobin.
Formation and release of up to 32 daughter merozoites
per infected cell occur during the schizont stage, which
lasts 8–10 h.
The food vacuole is a lysosome-like organelle unique to
the genus 
 
Plasmodium
 
. It is the site of massive hemoglobin
degradation during the trophozoite stage (Banerjee and
Goldberg, 2000) and is the target of several important anti-
malarial drugs (Ziegler et al., 2001). Endocytosis of erythrocyte
cytoplasm in trophozoites occurs mainly via invagination of
the parasite plasma membrane and the parasitophorous
vacuolar membrane through a specialized opening called the
cytostome (Aikawa et al., 1966; Slomianny et al., 1985;
Slomianny, 1990). In 
 
P. falciparum
 
, double-membrane
hemoglobin-containing transport vesicles pinch off from the
cytostome and fuse with the food vacuole, releasing a single-
membrane vesicle into the lumen (Yayon et al., 1984;
Slomianny, 1990). Hemoglobin catabolism in the food
vacuole is achieved through a semi-ordered sequence of
proteolytic events involving the aspartic proteases plasmepsins
(PMs) I, II, and IV (Francis et al., 1994; Gluzman et al., 1994;
Banerjee et al., 2002; Wyatt and Berry, 2002), histo-aspartic
protease (HAP; Banerjee et al., 2002), cysteine proteases
(Shenai et al., 2000; Sijwali et al., 2001), and a metalloprotease
(Eggleson et al., 1999). Cytosolic aminopeptidases may
participate in the terminal steps of degradation (Kolakovich
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et al., 1997). Residual heme is sequestered as a crystalline
pigment called hemozoin (Hempelmann and Egan, 2002).
The means by which newly synthesized proteins reach the
food vacuole are poorly understood. Several observations
suggest that some resident food vacuole proteins traverse the
‘classical’ secretory pathway. Maturation of PM I, II, and
HAP is blocked by treatment of parasites with brefeldin A
(BFA), an inhibitor of anterograde protein traffic from the
ER (Francis et al., 1997a; Banerjee et al., 2003). PM I has
been detected at the parasite plasma membrane and in cy-
tostomal vacuoles and hemoglobin-containing transport ves-
icles, which suggests a trafficking route that takes advantage
of the hemoglobin endocytic pathway (Francis et al., 1994).
Histidine-rich protein II is transported to the erythrocyte cy-
tosol in a BFA-sensitive manner (Akompong et al., 2002),
and small amounts may be transported along with hemoglo-
bin to the food vacuole via the cytostome (Sullivan et al.,
1996); alternatively, a direct trafficking route from the ER
to the food vacuole has been proposed (Akompong et al.,
2002). The reporter GFP, when targeted through the secre-
tory pathway to the parasitophorous vacuole, is thought to
be transported to the food vacuole in small packets of parasi-
tophorous vacuole lumen that are incorporated into cy-
tostomal vacuoles (Wickham et al., 2001; Adisa et al.,
2003). It is unclear whether any endogenous plasmodial
proteins traffic to the food vacuole in this fashion.
A better understanding of PM trafficking and maturation
may have practical application in the development of novel
antimalarial strategies, because disruption of PM function in
the food vacuole is expected to impair parasite survival
(Coombs et al., 2001). PM I and II are synthesized as ungly-
cosylated type II integral membrane proenzymes (Francis et
al., 1997a), with the membrane-spanning domain in the
proregion. Removal of the proregion and release of soluble
mature PM (mPM) in vivo and in vitro has been shown to
require an acidic environment and an activity blocked by the
cysteine protease inhibitor 
 
N
 
-acetyl-
 
L
 
-leucyl-
 
L
 
-leucyl-
 
L
 
-nor-
leucinal (ALLN) but not by the aspartic protease inhibitor
pepstatin (Francis et al., 1997a; Banerjee et al., 2003). These
observations have led to the idea that PM maturation is not
autocatalytic, but rather that the proenzymes are processed
by a “PM convertase” activity in the food vacuole (Francis et
al., 1997b; Banerjee et al., 2003).
Here, we have analyzed the trafficking and maturation of
a proPM II–GFP chimera. These studies were conducted
with a transgenic parasite line in which the chromosomal
copy of the PM II gene was modified to encode proPM II–
GFP. First, we demonstrated that the GFP tag does not in-
terfere with the transport and maturation of PM II, and
then we characterized the route taken by proPM II–GFP to
the food vacuole.
 
Results
 
Generation of transgenic parasites
 
The single-copy PM II gene of 
 
P. falciparum
 
 strain 3D7 was
altered to encode a proPM II–GFP fusion by modifying an es-
tablished gene disruption procedure (Crabb et al., 1997a).
Plasmid pPM2GT was constructed with a targeting sequence
of 1 kb of the 3
 
 
 
 end of the PM II coding region fused
in-frame to a sequence encoding a linker and the enhanced
GFP variant GFPmut2 (Fig. 1 A). Parasites transfected with
pPM2GT were selected with the antifolate drug WR99210
and subjected to two rounds of drug cycling to enrich the
population for parasites that had integrated pPM2GT into
the PM II gene (Fig. 1, B and C). Single-cell cloning of the
twice-cycled culture was undertaken to obtain parasites of de-
fined genotype. The clone studied extensively here, designated
B7, contains a single copy of pPM2GT integrated into the
PM II gene (Fig. 1 C).
Figure 1. Creation of a chromosomal PM II–GFP chimera. (A) Sche-
matic diagram of the integration plasmid pPM2GT linearized at the 
unique XhoI site (X). 1 kb of the 3  end of the PM II coding sequence 
(gray box) was fused in frame to a linker sequence followed by the 
GFPmut2 open reading frame (white box). The amino acid sequence 
of the linker is shown. A WR99210-resistant variant of human dihy-
drofolate reductase (Fidock and Wellems, 1997) was incorporated as 
a selectable marker. The black bar indicates the PM II sequence used 
for probing Southern blots. Elements are not drawn to scale. (B) Sche-
matic representation of events leading to a chromosomal PM II–GFP 
chimera. Single-site homologous recombination between the episomal 
pPM2GT target sequence and the chromosomal PM II locus produces 
the PM II–GFP chimera. The integration event produces a full-length 
PM II ORF (designated PM IIa) fused to GFP and a downstream 
promoterless copy of the PM II target sequence (PM IIb). Some 
elements of the plasmid, including the drug-resistance cassette, have 
been omitted for clarity. (C) Southern blot of StuI–NotI digested total 
DNA from untransfected parasites (3D7), stably transfected parasites 
before cycling (cycle 0) and after one and two drug cycles, and from 
three clones (B7, C9, and F4). The identity of the StuI–NotI fragments 
is indicated at left. The band identified with an asterisk is of unknown 
origin and probably reflects a rearrangement of pPM2GT after trans-
fection. This figure was assembled from two experiments. wt locus, 
wild-type PM II locus. 
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Effect of the GFP tag on the expression, maturation, 
and location of PM II
 
Before examining the trafficking of the proPM II–GFP fu-
sion, it was necessary to demonstrate that the addition of the
GFP tag did not interfere with transport to and maturation
in the food vacuole. Like untagged proPM II, proPM II–
GFP is synthesized as an integral membrane proenzyme
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200307147/DC1). To assess whether proPM II–GFP is
appropriately processed to the mature protease (Fig. 2 A),
trophozoite extracts were examined by immunoblotting
with anti–PM II and anti-GFP antibodies (Fig. 2 B). Only
mPM II was observed in parasites containing a wild-type
copy of the PM II gene. mPM II was also the predominant
form of the protein in B7 parasites. Along with the prore-
gion, GFP appeared to be proteolytically cleaved from mPM
II, as the mobility of mPM II in SDS-PAGE was only
slightly slower than that from 3D7 parasites. This slight shift
in mobility presumably derives from retention of some of
the linker sequence at the COOH terminus of mPM II. Sig-
nificantly, addition of the GFP tag had a relatively small ef-
fect on the steady-state levels of mPM II: densitometric
quantitation of Fig. 2 B using BiP as a normalization refer-
ence indicated that the amount of mPM II in B7 extract was
only 1.2-fold greater than that in transfected parasites before
cycling (cycle 0) and 1.6-fold greater than that in 3D7 ex-
tract. In addition to mPM II, a small but significant amount
of proPM II–GFP was observed in extracts of B7 parasites;
in contrast, proPM II was not detected in 3D7 extracts. Im-
munoblotting with anti-GFP antibodies indicated that GFP
is undetectable in stably transfected parasites before drug cy-
cling, which demonstrates that integration of pPM2GT into
the PM II gene is a prerequisite for GFP expression.
Direct evidence for the transport of PM II to the food vac-
uole was obtained by immunoEM with an affinity-purified
anti–PM II antibody. Significant amounts of antibody label
were detected in the food vacuole in B7 parasite sections
(Fig. 2 C), a result consistent with previous observations in
wild-type parasites (Banerjee et al., 2002).
The biosynthesis and maturation of proPM II and the
closely related proteins proPM I, proPM IV, and proHAP
have been shown to proceed relatively rapidly, with a half-
time of 
 
 
 
20 min (Francis et al., 1997a; Banerjee et al., 2003).
To determine the effect of the GFP tag on the rate of matura-
tion of proPM II, B7 parasites were pulse labeled with
[
 
35
 
S]methionine and -cysteine, chased for various times, and
polypeptides containing PM I, PM II, or GFP were immuno-
precipitated (Fig. 3). The PM II and GFP immunoprecipita-
tions indicated that proPM II–GFP was processed to mPM II
and GFP without significant accumulation of the intermedi-
ate forms proPM II or mPM II–GFP, which suggests that PM
II maturation and cleavage at the PM II–GFP linker occur es-
sentially simultaneously (Fig. 3, A and B). The rate of disap-
pearance of proPM II–GFP was considerably slower than that
of proPM I. After 45 min, a significant amount of proPM II–
GFP remained unprocessed (Fig. 3 B), whereas proPM I was
completely converted to mPM I (Fig. 3 C). This slower rate of
processing may be a factor in the elevation of steady-state lev-
els of proPM II–GFP observed in the immunoblots.
 
proPM II–GFP traverses the ER and cytostomal 
vacuoles on the way to the food vacuole
 
The distribution of GFP in live B7 parasites was followed
over the course of the 
 
 
 
44 h intraerythrocytic asexual repro-
ductive cycle by epifluorescence microscopy. The food vacu-
Figure 2. PM II–GFP expression in B7 parasites. (A) Schematic 
representation of the proPM II–GFP fusion. The propiece is shown 
with the single transmembrane domain (TM) in black. proPM II–GFP 
is proteolytically processed twice (arrowheads) to generate mPM II 
(gray box). (B) Immunoblot analysis of PM II and GFP expression in 
synchronized trophozoites before and after integration of pPM2GT. 
SDS-solubilized protein from 10
7 saponin-treated trophozoites was 
loaded in each lane. To assess relative amounts of protein loaded, 
blots were stripped and reprobed with anti-PfBiP antibody (bottom). 
Recombinant mature PM II (rmPM II) was used as a marker in the 
PM II blot. The species labeled “GFP” comigrated with recombinant 
GFPmut2 (not depicted). The band denoted with an asterisk reacted 
with secondary anti–rabbit Ig antibody alone (not depicted). Sizes of 
molecular mass markers are indicated in kD. (C) Immunoelectron 
micrograph illustrating labeling of the food vacuole of a B7 tropho-
zoite with affinity-purified anti–PM II. The food vacuole membrane is 
indicated with arrowheads, and the closely apposed parasitophorous 
vacuole and parasite plasma membranes are indicated with an arrow. 
A low magnification image of this parasite is provided in Fig. S2, 
http://www.jcb.org/cgi/content/full/jcb.200307147/DC1. fv, food 
vacuole. Bar, 200 nm. 
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ole of trophozoites and schizonts contained abundant GFP
(Fig. 4), which indicates that it is transported along with PM
II to this organelle. In some parasites, particularly younger
trophozoites, GFP fluorescence was observed in a perinu-
clear ring-like structure adjacent to the food vacuole (Fig. 4
A). The perinuclear distribution of GFP suggested that it
might be within the nuclear envelope. Further analysis of
this compartment in the presence of BFA is described in the
next section. Also in trophozoites, some GFP fluorescence
was concentrated in a small number of spots or foci (2.4 
 
 
 
1.2 foci per trophozoite, range 0–5, 
 
n
 
 
 
 
 
 35) that often re-
sided at the periphery of the parasite (Fig. 4 B). In parasites
undergoing nuclear division (schizonts), fluorescence was
limited to the food vacuole (Fig. 4 C). No fluorescence was
observed in association with individual merozoites in seg-
mented schizonts or in ring-stage parasites. Similar GFP dis-
tributions were observed with the cloned parasite lines C9
and F4 (unpublished data).
To define the distribution of GFP at the ultrastructural
level, B7 parasites were fixed and analyzed by immunoEM
with an affinity-purified anti-GFP polyclonal antibody. To
first assess the specificity of the antibody, untransfected 3D7
trophozoites were subjected to the labeling protocol. Approx-
imately one colloidal gold particle per parasite was observed,
with no clear labeling pattern in evidence. In contrast, sec-
tions of B7 trophozoites exhibited heavily labeled food vacu-
oles (Fig. 5 A). The membranes of cytostomal vacuoles were
also frequently labeled (Fig. 5, B and C), an observation that
provided the first indication that proPM II–GFP populates
the cytostomal vacuolar membrane (presumably the outer
membrane; see Discussion) en route to the food vacuole. Al-
though the protein collar of the cytostomal pore itself is
poorly visible in these sections, the neck of the cytostomal
vacuole, the continuity between the erythrocyte cytosol and
the vacuole lumen, and the two membranes making up the
vacuole are all evident in Fig. 5 (B and C). Double-mem-
brane structures that may be cross sections of the cytostomal
vacuole or hemoglobin transport vesicles are shown in Fig. 5
(D and E). Given the location of cytostomes at the periphery
of the parasite and the apparent paucity of immunogold label
elsewhere in the vicinity of the parasite plasma membrane,
we presume that the peripheral GFP foci seen in live parasites
(Fig. 4 B) correspond to cytostomal vacuoles.
 
proPM II–GFP populates the nuclear envelope 
and the peripheral ER upon BFA treatment
 
BFA has enjoyed wide application due to its ability to in-
hibit anterograde protein trafficking from the ER; however,
it has been shown to affect protein transport to and from or-
ganelles other than the ER, such as the endosomal–lysoso-
mal system (Klausner et al., 1992). BFA inhibits processing
of proPM II to mPM II (Francis et al., 1997a), presumably
because proPM II cannot reach the food vacuole. To better
understand the root cause of inhibition of PM maturation,
and to characterize the morphology of the BFA-induced
structure(s) in live parasites, we analyzed the distribution of
GFP fluorescence in B7 parasites treated with 5 
 
 
 
g/ml BFA
for 2 h. In trophozoites, a prominent perinuclear ring of
fluorescence was observed (Fig. 6 A). The morphology of
this structure closely resembled that observed in untreated
Figure 3. Pulse-chase analysis of proPM II–GFP maturation. B7 
trophozoites were pulse labeled for 15 min with [
35S]methionine 
and -cysteine and chased for the times indicated (min). (A) Immuno-
precipitation of PM II–containing species. To indicate the position 
of proPM II (without GFP), this species was immunoprecipitated from 
labeled wild-type 3D7 parasites. In the B7 lanes, proPM II–GFP is 
partially obscured by high background in this region of the gel. 
(B) Immunoprecipitation of polypeptides containing GFP. The low 
intensity of the GFP band relative to proPM II–GFP is likely due to 
two factors: GFP contains one third of the label present in proPM II–
GFP, and may be slowly degraded in the food vacuole. (C) Immuno-
precipitation of pro- and mPM I. Parasites are from the same labeled 
populations as those in B.
Figure 4. GFP fluorescence in live B7 parasites. (A) A trophozoite 
exhibiting GFP fluorescence in the food vacuole (arrowhead) and in a 
perinuclear ring (arrow). Fluorescence from the nuclear stain Hoechst 
33342 is pseudocolored red. (B) A trophozoite with a fluorescent 
food vacuole (arrowhead) and a bright fluorescent spot (arrow) that 
lies at the periphery of the parasite. (C) A mature parasite displaying 
a large fluorescent food vacuole. Note the absence of fluorescence 
outside of the food vacuole. Bar, 2  m. 
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trophozoites (Fig. 4 A), but the intensity of fluorescence was
greatly increased by BFA treatment. The number of fluores-
cent foci was greatly diminished (0.14 
 
 
 
 0.35 per trophozo-
ite, range 0–1, 
 
n
 
 
 
 
 
 29), which suggests a depletion of
cytostomal fluorescence upon BFA treatment. In early
schizonts, the fluorescent compartment developed greater
complexity and consisted of multiple perinuclear rings (Fig.
6 B). The perinuclear position of this compartment sug-
gested that it was the nuclear envelope, a structure that in
many eukaryotic cells is continuous with the ER lumen
(Franke et al., 1981). To confirm this, B7 trophozoites were
treated with BFA for 2 h and then fixed and sectioned for
immunoEM. Both GFP and the resident ER protein BiP
were localized in the same sections using secondary antibod-
ies conjugated to 18- and 12-nm colloidal gold, respectively.
Much of the GFP label was associated with the nuclear enve-
lope, but some was also observed in elements of the periph-
eral ER, which consists of tubulovesicular structures extend-
ing away from the nucleus toward the parasite plasma
membrane (Fig. 6 D). The bulk of the BiP label was associ-
ated with the peripheral ER, although it could also be de-
tected in the nuclear envelope (Fig. 6 D and unpublished
data). In some sections, continuity between the nuclear en-
velope and tubulovesicular elements of the peripheral ER
could be observed (unpublished data).
Transport of proPM II–GFP downstream of the ER was
followed in live parasites by washing out BFA in the pres-
ence of cycloheximide, an inhibitor of protein synthesis. 10
min after release of the BFA block, fluorescence was once
again visible in cytostomal vacuoles before the appearance of
significant fluorescence in the food vacuole (Fig. 6 C). These
observations are consistent with a pathway for proPM II–
GFP trafficking that proceeds from the ER/nuclear envelope
to cytostomal vacuoles and then to the food vacuole.
To confirm that proPM II–GFP synthesized during BFA
treatment was not proteolytically processed and thus retained
the GFP tag, B7 trophozoites were 
 
35
 
S-labeled for 2 h in
medium containing 5 
 
 
 
g/ml BFA. When GFP-containing
polypeptides were immunoprecipitated, full-length proPM
II–GFP but not free GFP was observed (Fig. 6 E). Upon
washout of BFA and a further 2 h incubation at 37
 
 
 
C, nearly
all of the labeled proPM II–GFP disappeared and 
 
35
 
S-labeled
GFP appeared (Fig. 6 E), a result consistent with release of
the secretion block, transport of labeled proPM II–GFP to
the food vacuole, and proteolytic cleavage of GFP from
mPM II. Washout of BFA after 2 h followed by culturing for
96 h in the absence of BFA provided confirmation that the
parasites were viable throughout the BFA treatment period.
 
proPM II–GFP accumulates in the food vacuole 
membrane upon treatment with the PM maturation 
inhibitor ALLN
 
ALLN is a tripeptide aldehyde inhibitor of cysteine proteases
(Sasaki et al., 1990) that prevents the maturation of proPM
II in vivo and in vitro (Francis et al., 1997a; Banerjee et al.,
2003). Because ALLN does not inhibit PM II activity, this
result has been interpreted as evidence for an ALLN-inhib-
itable PM convertase in the food vacuole (Francis et al.,
1997a; Banerjee et al., 2003); however, an indirect effect of
ALLN treatment on PM II processing, for example by inter-
fering with transport to the food vacuole, has been difficult
to rule out. To better define the effect of ALLN, we local-
ized proPM II–GFP in B7 trophozoites in which PM matu-
ration had been blocked by this inhibitor.
To better visualize proPM II–GFP fluorescence against a
background of GFP in the food vacuole, B7 parasites were
first treated with BFA for 2 h to accumulate proPM II–
GFP, and then the BFA was washed out in the presence of
100 
 
 
 
M ALLN. A marked redistribution of proPM II–
GFP was observed in live parasites upon replacement of
BFA with ALLN. The perinuclear ring of fluorescence ob-
served upon BFA treatment disappeared and was replaced
by a fluorescent rim around the food vacuole (Fig. 7, A and
B). In many parasites, regions of more intense fluorescence
could be observed within this rim (Fig. 7 A). These may re-
flect a local concentration of proPM II–GFP in the food
vacuole membrane, or may arise from the docking of trans-
Figure 5. ImmunoEM localization of GFP to the food vacuole and 
cytostomal vacuoles. (A) A B7 trophozoite displaying prominent 
food vacuole labeling. Bar, 200 nm. (B and C) Cross sections of 
cytostomal vacuoles formed during the uptake of erythrocyte cytosol 
showing labeling of the vacuole membrane. In both panels, the “neck” 
of the cytostome (arrows) is clearly visible. (D and E) Cross sections 
of cytostomal vacuoles or hemoglobin transport vesicles displaying 
membrane labeling. Low magnification images of parasites in B–E 
are provided in Fig. S2. fv, food vacuole; n, nucleus; pvm, parasito-
phorous vacuole membrane; cv, cytostomal vacuole; ec, erythrocyte 
cytoplasm; ct, cytostomal vacuole or hemoglobin-containing trans-
port vesicle. (B–E) Bars, 100 nm. 
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port vesicles to the food vacuole; an explanation for this
phenomenon was not obvious from immunoEM experi-
ments. In addition, peripheral fluorescent spots indicative
of cytostomal vacuoles were seen (Fig. 7 A). The observa-
tion of fluorescence circumscribing the food vacuole sug-
gested that the integral membrane protein proPM II–GFP
had been transported to the food vacuole and, in the ab-
sence of cleavage of proPM II or GFP, remained anchored
in the food vacuole membrane. To confirm this idea, B7
parasites treated sequentially with BFA and ALLN were an-
alyzed by immunoEM with either anti-GFP or anti–PM II
antibody. In contrast to the lumenal labeling observed with
untreated parasites (Fig. 2 C and Fig. 5 A), BFA/ALLN-
treated parasites exhibited accumulation of gold label pri-
marily at the food vacuole membrane (Fig. 7, C and D).
Control experiments confirmed that parasites remained via-
ble throughout the BFA and ALLN treatments.
To ensure that GFP was covalently associated with proPM
II after washout of BFA in the presence of ALLN, B7 tro-
Figure 6. BFA induces a reversible accumulation 
of proPM II–GFP in the ER. (A and B) GFP fluores-
cence in live B7 parasites treated for 2 h with BFA: 
(A) a trophozoite and (B) a schizont undergoing 
nuclear division. The arrowhead in B indicates food 
vacuole fluorescence. (C) Redistribution of GFP 
10 min after release of the BFA block. Fluorescent 
spots reappear at the periphery of the parasite 
(arrowheads). 100  g/ml cycloheximide was present 
to inhibit protein synthesis after BFA washout. 
Similar results were obtained in the absence of 
cycloheximide. In A–C, fluorescence from the 
nuclear stain Hoechst 33342 is pseudocolored red. 
Bar, 2  m. (D) Cryosection of a BFA treated B7 
trophozoite double-labeled with an antibody against 
GFP (18-nm colloidal gold) and an antibody recog-
nizing the ER marker BiP (12-nm colloidal gold). 
Most of the 18-nm gold label is associated with the 
nuclear envelope (arrowhead), whereas the 12-nm 
gold label is associated with the peripheral ER 
(asterisk) extending away from the nucleus. A low 
magnification image of this parasite is provided in 
Fig. S2. n, nucleus. Bar, 200 nm. (E) B7 trophozoites 
were 
35S-labeled for 2 h in the presence of 5  g/ml 
BFA (“BFA” lane). Both BFA and unincorporated 
35S 
were washed out either in the absence (no inhib) or 
presence (ALLN) of an inhibitor of PM II maturation. 
proPM II–GFP and GFP were immunoprecipitated 
with an anti-GFP antibody. The low intensity of the 
GFP band in “no inhib” lane relative to proPM
II–GFP in the “BFA” lane is likely due to two
factors: GFP contains one third of the label 
present in proPM II–GFP, and may be slowly
degraded in the food vacuole. Sizes of molecular 
mass markers are indicated in kD.
 
Figure 7.
 
 ALLN treatment results in accumulation of proPM II–GFP 
in the food vacuole membrane.
 
 (A) GFP fluorescence in a live B7 
trophozoite treated with BFA for 2 h followed by replacement of BFA 
with 100 
 
 
 
M ALLN for a further 2 h. A bright rim of fluorescence 
circumscribes the food vacuole (arrow). A local concentration of 
fluorescence on the food vacuole membrane is indicated with an 
arrowhead. Two cytostomal vacuoles above the food vacuole are 
also visible. Bar, 2 
 
 
 
m. (B) A trophozoite treated as in A in which 
the Hoechst 33342–stained nucleus is pseudocolored red. (C and D) 
Trophozoites treated as in A and labeled with either (C) anti-GFP or 
(D) anti–PM II antibody. Low magnification images of these parasites 
are provided in Fig. S2. Abbreviations are given in the legend to 
Fig. 5. Bars, 200 nm. 
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phozoite proteins were 
 
35
 
S-labeled in the presence of BFA to
accumulate [
 
35
 
S]-proPM II–GFP, and both BFA and 
 
35
 
S-
label were washed out in the presence of 100 
 
 
 
M ALLN.
No diminution of the amount of labeled proPM II–GFP
was observed after 2 h incubation with ALLN and no la-
beled GFP appeared (Fig. 6 E), which indicates that ALLN
inhibited both the maturation of proPM II and cleavage of
GFP from PM II.
 
Discussion
 
We have tagged the chromosomal copy of the 
 
P. falcip-
arum
 
 PM II coding sequence with that of GFP in order to
facilitate analysis of PM trafficking. The GFP tag had a rel-
atively small effect on steady-state mPM II levels in tro-
phozoites. Although GFP did not remain covalently linked
to mPM II, cleavage of GFP from PM II occurred simulta-
neously with conversion of proPM II to the mature form
of the enzyme. Thus, GFP was considered to be a faithful
reporter of the location of proPM II in the parasite up to
the point of maturation. Small amounts of proPM II–GFP
accumulated in B7 parasites, whereas proPM II in wild-
type parasites was undetectable. The difference in proen-
zyme levels is likely attributable to the slower rate of matu-
ration of proPM II–GFP, which in turn probably derives
from a decreased rate of transport to the food vacuole. The
GFP tag may delay folding of proPM II in the ER, or may
delay recruitment of proPM II to ER exit sites. We antici-
pate that the strategy described here for the fusion of tags
to the COOH terminus of proteins will be a useful addi-
tion to the 
 
P. falciparum
 
 genetic tool box.
Trafficking of PMs begins in the ER, where they are in-
serted as type II integral membrane proteins (Francis et al.,
1997a). We have shown that BFA treatment induces accu-
mulation of proPM II–GFP in a perinuclear compartment
in live parasites. This compartment was identified as the nu-
clear envelope and the peripheral ER by immunoEM. This
is, to our knowledge, the first description of the morphology
of the ER in live trophozoites after a relatively brief exposure
to BFA. The prominent perinuclear distribution of the ER is
reminiscent of that observed in other unicellular organisms
(in the absence of BFA) such as 
 
Saccharomyces cerevisiae
 
 and
 
Toxoplasma gondii
 
 (Preuss et al., 1991; Hager et al., 1999).
Our results, along with a recent report of colocalization of
PM IV and BiP in fixed BFA treated parasites (Banerjee
et al., 2003), indicate that the previously observed BFA-
induced block in PM maturation derives from an inability
to exit the ER. There is some evidence to suggest that ER
exit sites (transitional ER) may be located in the nuclear en-
velope of 
 
P. falciparum
 
. In developing 
 
P. falciparum
 
 merozo-
ites, vesicle budding from the apical face of the nuclear enve-
lope has been documented (Langreth et al., 1978; Bannister
and Mitchell, 1995; Ward et al., 1997), and budding of
coated vesicles from the nuclear envelope of a Taxol-treated
trophozoite has been observed (Taraschi et al., 1998).
In the absence of BFA, weak GFP fluorescence was ob-
served in the nuclear envelope in live parasites during a
narrow window of intraerythrocytic development: young
trophozoites, but not rings or mature trophozoites (distin-
guished by the lack of or abundance of hemozoin, respec-
 
tively), exhibited such fluorescence. Because the steady-state
level of mPM II increases as parasites mature (Banerjee et
al., 2002), a decrease in the rate of proPM II–GFP biosyn-
thesis in more mature parasites is unlikely to account
for the disappearance of fluorescence from the ER. A plau-
sible explanation for this phenomenon is that transport of
proPM II–GFP out of the nuclear envelope is relatively in-
efficient in young trophozoites and becomes more efficient
in older parasites.
The presence of proPM II–GFP in the membranes of cy-
tostomal vacuoles points to a role for a major hemoglobin
endocytic pathway in proPM II trafficking. The number
of cytostomal vacuoles visible by fluorescence microscopy
dropped dramatically when proPM II–GFP trafficking was
blocked with BFA, and fluorescent cytostomal vacuoles reap-
peared when the BFA block was relieved. These observations
are consistent with trafficking of proPM II–GFP from the
ER to cytostomal vacuoles, and in cytostomal vacuoles to the
food vacuole. It is presently not known whether proPM II–
GFP transits a post-ER compartment such as the Golgi ap-
paratus. A Golgi complex with a classic stacked cisternal
morphology has not yet been reported in 
 
P. falciparum
 
trophozoites, although several proteins associated with the
Golgi apparatus in mammalian cells have been identified in
this stage (Elmendorf and Haldar, 1993; de Castro et al.,
1996; Van Wye et al., 1996). Characterization of the Golgi
apparatus in trophozoites with antibodies against ERD2 has
revealed that it takes the form of a single, small, slightly elon-
gated perinuclear structure (Elmendorf and Haldar, 1993;
Van Wye et al., 1996). As this differs from the number and
location of fluorescent foci that we attribute to cytostomal
vacuoles in proPM II–GFP expressing trophozoites, it is un-
likely that these foci are Golgi structures.
Maturation of proPM II has been demonstrated to require
a proteolytic activity that is sensitive to inhibition by ALLN
(Banerjee et al., 2003; Francis et al., 1997b), a potent in-
hibitor of cathepsin L-type cysteine proteases and calpains
(Sasaki et al., 1990). Because proPM II–GFP synthesized in
the presence of BFA is not converted to mPM II, processing
must occur downstream of the ER. Upon washout of BFA in
the presence of ALLN, proPM II–GFP exited from the ER
and populated the food vacuole membrane. This result dem-
onstrates that inhibition of proPM II–GFP processing does
not stem from interference with trafficking to the food vacu-
ole. Our observations are consistent with the notion that a
PM convertase activity is responsible for PM activation in an
acidic environment, namely the food vacuole (Francis et al.,
1994; Banerjee et al., 2003). We cannot exclude the possibil-
ity that proteolytic maturation occurs in transport vesicles on
the way to the food vacuole (Hempelmann et al., 2003);
however, this would appear to require cotrafficking of the
PM convertase and acidification of the transport vesicles,
events for which there is currently no evidence.
Together, these results suggest a trafficking pathway for
proPM II that takes advantage of the parasite’s nutritional re-
quirement for hemoglobin degradation (Fig. 8). We propose
that, after insertion into the ER, proPM II is transported to
the cytostome, where it accumulates and is brought to the
food vacuole along with its substrate, hemoglobin. In the
acidic environment of the food vacuole, the proenzyme is 
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cleaved and mature, active, soluble PM II is released. The
half-time for biosynthesis and maturation of untagged PMs
has been estimated to be 20 min (Francis et al., 1997a; Ban-
erjee et al., 2003). If PM II is trafficked exclusively through
the cytostome, we can estimate that the half-time for the de-
livery of cytostomal vacuolar contents to the food vacuole is
less than 20 min; however, our data do not exclude the possi-
bility of alternate PM II trafficking pathways such as direct
transport from the ER to the food vacuole.
Trafficking of food vacuole proteins to the cytostomal
vacuole would offer a simple means for de novo production
of food vacuoles. There is currently no evidence to suggest
that hemoglobin-degrading vacuoles are inherited by daugh-
ter merozoites, so this organelle may undergo de novo gene-
sis after each round of invasion. Rodent 
 
Plasmodium
 
 species
appear to degrade hemoglobin in multiple cytostome-
derived vacuoles that do not fuse into a large central food
vacuole until late in the erythrocytic cycle (Slomianny,
1990), which further suggests that a mechanism exists for
the de novo production of functional hemoglobin-degrading
vacuoles. It will be of interest to determine whether other
food vacuole proteins follow a similar route and whether
nonfood vacuole proteins share components of this pathway.
The data for trafficking of proPM II–GFP to the food
vacuole that we present here support some of the features of
a model put forward by Francis et al. (1994) for the trans-
port of proPM I albeit with important modifications. Exper-
iments with PM I could not resolve whether this protein was
membrane associated or lumenal in cytostomal vacuoles and
transport vesicles (Francis et al., 1994). Our data suggest a
model (Fig. 8) in which vesicular transport of PMs to the cy-
tostomal vacuole places the proenzyme within the space be-
tween the two vacuole membranes. The detection of low
levels of PM I at the parasite plasma membrane led Francis
et al. (1994) to propose that PM I is first transported to
the plasma membrane and then incorporated into the cy-
tostomal vacuole, possibly by passive lateral diffusion in the
plasma membrane. In contrast, we do not observe a similar
accumulation of proPM II–GFP in the parasite plasma
membrane either by fluorescence microscopy or immu-
noEM. Although the question of how proPM I and proPM
II–GFP reach the cytostome is far from resolved, we cur-
rently favor a model that incorporates direct vesicular trans-
port to the outer membrane of the cytostome.
 
Materials and methods
 
Vector construction
 
The gene for 
 
Aequorea victoria
 
 GFP allele GFPmut2 (Cormack et al., 1996)
was PCR amplified with forward primer 5
 
 
 
-CTCGAGGGCCCACTAGTG-
GTCCTAGGCCAGGTGCAGCACATTATGCAGCAATGAGTAAAGGAGA-
AGAACTTTTC-3
 
 
 
 (XhoI, SpeI, and AvrII restriction sites are underlined)
and reverse primer 5
 
 
 
-GTCGACGCGGCCGCTTATTTGTATAGTTCATCC-
ATGCC-3
 
 
 
 (SalI and NotI restriction sites are underlined), and cloned as an
XhoI–SalI fragment into the XhoI site of pHC1 (Crabb et al., 1997b) to pro-
duce pHCGFP. The last kilobase of the PM II ORF (omitting the stop
codon) was PCR amplified from 
 
P. falciparum
 
 3D7 genomic DNA with
primers 5
 
 
 
-GCACGCTCGAGTAAAATTATTTAGGTAGTTCAAATGATAA-
3
 
 
 
 (XhoI site underlined) and 5
 
 
 
-GCACGCCTAGGTAAATTCTTTTTAGCA-
AGAGCAATAC-3
 
 
 
 (AvrII site underlined), digested with XhoI and AvrII,
and ligated into the same sites of pHCGFP to create pPM2GFP. An XhoI–
HindIII fragment from pPM2GFP containing the PM II–GFP fusion se-
quence and the 
 
P. falciparum
 
 HSP86 3
 
 
 
 UTR was cloned into the same
sites of pSP72 (Promega) to generate pSPGFP. A drug-resistance cassette
containing human DHFR was excised from pHHT-TK (a gift of A. Cow-
man, Walter and Eliza Hall Institute of Medical Research, Melbourne, Aus-
tralia; Duraisingh et al., 2002) with BglII and EcoRI, and introduced into
the same sites of pSPGFP to yield pPM2GT.
 
Parasite culture and transfection
 
P. falciparum
 
 3D7 was cultured in human O
 
 
 
 erythrocytes at 37
 
 
 
C under
5% O
 
2
 
, 5% CO
 
2
 
, and 90% N
 
2
 
 in RPMI 1640 (GIBCO BRL), supplemented
with 27 mM sodium bicarbonate, 11 mM glucose, 0.37 mM hypoxan-
thine, 10 
 
 
 
g/ml gentamicin, and either 5 g/l Albumax (for routine growth;
GIBCO BRL) or 10% heat-inactivated human serum (for transfection and
cycling) as described previously (Trager and Jensen, 1976). Parasite cul-
tures were synchronized by sorbitol treatment (Lambros and Vanderberg,
1979). Ring-stage parasites were transfected by electroporation with 100
 
 
 
g of supercoiled pPM2GT using low voltage/high capacitance conditions
(Fidock and Wellems, 1997). Resistant parasites were selected with 10 nM
WR99210 (a gift of D. Jacobus, Jacobus Pharmaceuticals, Princeton, NJ)
and reached a parasitemia of 0.5% after 22 d. Selection for integration of
the episome into the PM II gene was achieved by subjecting WR99210-
resistant parasites to two drug cycles, each consisting of 21 d of growth in
the absence of WR99210 followed by reselection of resistant parasites.
Parasites were cloned by the method of limiting dilution. Genotypes were
analyzed by probing Southern blots of NotI–StuI-digested total parasite
DNA with a gel-purified PCR product extending from bases 496 to 1143 of
the PM II gene. The signal was generated with an AlkPhos direct labeling
and detection kit (Amersham Biosciences).
 
Western and pulse-chase analysis
 
For immunoblotting, synchronized trophozoites were separated from
erythrocyte cytosol by treatment with cold 0.1% saponin in PBS for 15 min
on ice followed by two washes in cold PBS. Saponin-treated parasites were
counted with a hemocytometer and frozen at 
 
 
 
80
 
 
 
C until use. Frozen par-
asite pellets were rapidly suspended in SDS-PAGE sample buffer at 10
 
6
 
parasites/
 
 
 
l, placed immediately in a boiling water bath for 5 min and cen-
trifuged at 16,000 
 
g
 
 for 5 min to remove insoluble material. Protein ex-
tracted from 10
 
7
 
 parasites was resolved by 10% SDS-PAGE and blotted to
Figure 8. Model for trafficking of proPM II–GFP to the food vacuole. 
This model is based on data presented here and elsewhere (Francis 
et al., 1994, 1997a). proPM II–GFP is inserted as a type II membrane 
protein into the ER/nuclear envelope (NE). Transport vesicles 
containing proPM II–GFP bud from ER exit sites in a BFA-sensitive 
manner. The vesicles migrate to the cytostome (possibly via a Golgi-
like compartment) and fuse with the outer membrane of the cytostomal 
vacuole, which is topologically contiguous with the parasite plasma 
membrane. This event would place proPM II–GFP in the space 
between the two vacuole membranes. The double-membrane 
hemoglobin transport vesicle pinches off from the cytostome, migrates 
to the food vacuole, and its outer membrane fuses with that of the 
food vacuole, leaving proPM II–GFP anchored in the food vacuole 
membrane. The proregion of PM II and GFP are proteolytically 
removed to yield mPM II, a process that is inhibited by ALLN. Black 
circles, PM II; white circles, GFP; PVM, parasitophorous vacuole 
membrane; PPM, parasite plasma membrane; Hb, hemoglobin. 
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nitrocellulose. Antibodies used for immunodetection were rabbit anti–PM
II Ab 737 (1:5,000) raised against a peptide corresponding to the NH
 
2
 
 ter-
minus of mPM II (Francis et al., 1997a), affinity-purified rabbit anti-GFP
ab6556 (1:5,000; Abcam) or rabbit anti-BiP (1:10,000; Kumar et al., 1991).
The signal was developed with an HRP-conjugated anti–rabbit Ig second-
ary antibody and ECL Western blotting detection reagents (Amersham Bio-
sciences). Recombinant PM II was a gift from E. Istvan (Washington Uni-
versity, St. Louis, MO).
For pulse-chase analysis, a synchronized trophozoite culture (10–15%
parasitemia) was washed twice with RPMI 1640 without cysteine, methi-
onine, and glutamine (Sigma-Aldrich), and incubated at 4% hematocrit
for 15 min at 37
 
 
 
C in the same medium supplemented as described pre-
viously (Banerjee et al., 2003) but with 180  Ci/ml [
35S]methionine and
-cysteine (EXPRE
35S
35S, NEN). The chase period was initiated either by re-
placing the labeling medium with complete RPMI (PM II immunoprecipi-
tations) or by addition of an equal volume of complete RPMI (GFP and
PM I immunoprecipitations), and the parasites were incubated at 37 C in
a 5% CO2 environment. At the desired time, a 12-ml aliquot of the cul-
ture was removed and placed on ice. Culture aliquots were washed once
in cold PBS, treated with 1.5 pellet volumes of 0.15% saponin in PBS for
10 min on ice, washed once with cold PBS, and stored at  80 C. PMs
were immunoprecipitated from denatured parasite lysates as described
previously (Francis et al., 1997a) using anti–PM I Ab574 (1:200) or affin-
ity-purified anti–PM II Ab737 (1:20). GFP was immunoprecipitated in the
absence of SDS using living colors full-length A.v. polyclonal anti-GFP
antibody (1:500; BD Biosciences). A cocktail of protease inhibitors
(1  M pepstatin, 10  M bestatin, 10  M ALLN, 1  M leupeptin, 1  M
N-[trans-epoxysuccinyl]-L-leucine-4-guanidinobutylamide, and 0.5 mM
4-[2-aminoethyl]-benzenesulfonylfluoride) was added to the GFP immu-
noprecipitations.
The effect of BFA and ALLN on proPM II–GFP maturation was assayed
by modifying the pulse-chase protocol as follows: 5  g/ml BFA/0.1%
DMSO was added to the 
35S-containing labeling media, hematocrit was
reduced to 2% and the labeling time was extended to 2 h, at which point
an aliquot was placed on ice (BFA sample). The remaining culture was
split into two aliquots, washed three times with complete media contain-
ing either 100  M ALLN/0.1% DMSO or 0.1% DMSO, and incubated for
an additional 2 h at 37 C. Parasites were released by saponin treatment
and GFP-containing species were immunoprecipitated as described in
the preceding paragraph.
Fluorescence and immunoEM
Fluorescence and phase contrast images were collected using a Plan-Neo-
fluar 100x/1.3 NA objective on an Axioscope microscope (Carl Zeiss Mi-
croImaging, Inc.) equipped with a Axiocam CCD camera and Axiovision
3.1 software (Carl Zeiss MicroImaging, Inc.). For imaging of live parasites,
cultures were maintained in RPMI 1640 media without phenol red
(GIBCO BRL) supplemented as described in parasite culture and transfec-
tion. 10  l of culture was placed underneath a coverslip and viewed at
ambient temperature for a maximum of 10 min. Nuclei were visualized by
adding 5  M Hoechst 33342 (Molecular Probes) to aliquots of parasite
cultures immediately before mounting. Quantitation of GFP-fluorescent
foci was done by visual examination while adjusting the focus to sample
all focal planes through the specimen. For analysis of the effects of BFA,
parasites were cultured in media containing 5  g/ml BFA/0.1% DMSO for
2 h before observation. BFA was removed from the culture by washing
twice and resuspending to 2% hematocrit with BFA-free media containing
100  g/ml cycloheximide/0.1% DMSO. ALLN-treated cultures were first
incubated with 5  g/ml BFA/0.1% DMSO for 2 h, the BFA was removed
by washing three times with media containing 100  M ALLN/0.1%
DMSO, and the parasites were cultured for an additional 2 h. Images were
imported into Adobe Photoshop for contrast enhancement, pseudocolor-
ing, and creation of overlays.
For immunolocalization by EM, infected RBCs were separated from cul-
ture media by centrifuging at 860 g for 3 min, and were fixed and prepared
for labeling as described previously (Banerjee et al., 2002). BFA- and BFA/
ALLN-treated parasites were cultured as described for fluorescence micros-
copy, and the fix solution was supplemented with 5  g/ml BFA and 100
 M ALLN, respectively. 70-nm sections were incubated with either affin-
ity-purified rabbit anti–PM II Ab737 (1:100) or rabbit anti-GFP ab6556
(1:1,000 or 1:2,000) followed by 18-nm colloidal gold-conjugated anti–
rabbit IgG (Jackson ImmunoResearch Laboratories). For double-labeling
experiments, rat anti-BiP antibody (1:400; Malaria Research and Reference
Reagent Resource Center, American Type Culture Collection) was used
with a 12-nm colloidal gold-conjugated anti–rat IgG secondary antibody
(Jackson ImmunoResearch Laboratories). Sections were stained with 0.3%
uranyl acetate/2% polyvinyl alcohol and viewed on a transmission elec-
tron microscope (model 1200EX; JEOL).
Online supplemental material
Fig. S1 shows that proPM II–GFP is an integral membrane protein. Fig. S2
contains low magnification immunoEM images of the parasites depicted in
Figs. 2 C, 5 (B–E), 6 D, and 7 (C and D). Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200307147/DC1.
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